Congenital Nephrotic Syndrome in Oman: A 20-year single-centre experience Authors: Muzna Al Hashmi, Anisa Al Maskari, Sulaiman Al Saidi, Badria Al Ghaithi, Mohammed Al Riyami, Naifain Al Kalbani Published: 2026 ABSTRACT SummaryObjectives:Congenital nephrotic syndrome (CNS) is a rare, severe disease presenting within the first three months of life, with limited prevalence data from Oman and the Gulf region. This study aimed to report 20 years’ experience of congenital nephrotic syndrome (CNS) in a single centre in Oman.Methods:This retrospective study including children diagnosed with nephrotic syndrome in first 3 months of life, from January 2000 to December 2020 at Royal Hospital, Muscat, Oman.ResultsA total of 26 patients were included in the study, with no gender predominance. Consanguinity was noted in 61.5% of patients and a family history of renal disease was found in 46.2% of patients. The median age at presentation was 19.9 days (range: birth–2 months). Genetic workup was performed in 19 patients of which 73.6% were positive for NPHS1 gene. The median follow-up was 6.3 years (range: 1 month–13 years). Dialysis was initiated in 23.1% of patients, and 15.4% underwent transplantation. The median age at death was 1.5 years (range: 1 month–7 years).Conclusion:Genetic factors remain the predominant cause of CNS in this study's cohort. Despite significant disease course, advances in supportive and specialised care continue to improve outcomes. 1. Introduction Congenital nephrotic syndrome (CNS) is a rare type of nephrotic syndrome that occurs in infants in the first 3 months of life. It is defined by severe proteinuria, hypoalbuminemia and significant oedema.1 Historically, CNS was associated with extremely poor outcomes, with many infants dying in early infancy from infections, thrombosis or haemodynamic instability before the advent of modern supportive care and kidney transplantation. Over recent decades, advances in genetic testing, nutritional support, albumin replacement, dialysis and transplantation have significantly improved survival. Nevertheless, CNS remains a highly challenging condition that requires intensive multidisciplinary management because affected children are vulnerable to recurrent infections, thrombotic complications, growth failure and progression to kidney failure.1 CNS can be divided into hereditary/primary CNS and non-hereditary (secondary, primarily infectious) CNS. Hereditary CNS is caused mainly by genetic defects affecting podocyte proteins, particularly mutations in genes such as NPHS1, NPHS2, WT1 and LAMB2, leading to disruption of the glomerular filtration barrier.2 In regions with high rates of consanguinity, such as the Middle East, genetic forms of CNS appear to be particularly important, emphasising the need for local data to better understand disease patterns, outcomes and management challenges within the regional population. Oman has a population of approximately 5 million people and a high rate of consanguinity estimated at 52%.3 Given the strong genetic contribution to CNS, understanding the disease within the local population is particularly important. Therefore, this study aimed to share the authors’ 20-year experience, providing insights into the epidemiology, clinical presentation, genetic causes and long-term outcomes of children diagnosed with CNS in Oman. 2. Methods This retrospective descriptive cohort study was conducted at the Royal Hospital, Muscat, Oman, from January 2000 to December 2020 and included patients diagnosed with CNS. Royal Hospital serves as a national referral centre, caring for both Omani and non-Omani patients referred from across the country. It has the largest Paediatric Nephrology unit in the country. CNS was defined as nephrotic syndrome presenting during the first 3 months of life, with typical features including heavy proteinuria, hypoalbuminemia and oedema, according to international diagnosing criteria.1 All infants diagnosed and/or followed at the Royal Hospital during the study period were included in the study. Patients who developed nephrotic syndrome after 3 months of age, had transient proteinuria, insufficient clinical information or hypoalbuminemia due to non-renal causes were excluded. Data were derived from patient's electronic records (Al Shifa system). Data collected included gender, gestational age, placenta size and polyhydramnios. Clinical features of age at presentation, presenting complaints, family history of renal disease and consanguinity were recorded. Diagnostic measures included protein/creatinine ratio, albumin level, cholesterol level, thyroid function tests, virology studies, abdominal imaging and genetic workup. Infectious work-up included TORCH screen, hepatitis B and C screening. Patients’ outcomes and follow-up period were documented. Statistical analysis was performed using the Statistical Package for Social Sciences (SPSS) software, Version 28 (IBM Corp., Armonk, New York, USA). Descriptive statistics were used with categorical variables presented in terms of percentage and continuous variables reported as mean. 3. Results A total of 26 patients were included in the study. Patients’ demographics showed no gender predominance. Consanguinity was noted in 61.5% of the cases and a positive family history of renal disease was observed in 46.2%. The main clinical presentation was oedema, observed in a total of 80.5% of the patients (the oedema was variable in 42.0% of the cases and generalised oedema was limited to 38.5% of cases at presentation) [Table 1]. Table 1.Characteristics of patients with congenital nephrotic syndrome at Royal Hospital, Muscat, Oman (N = 26).Characteristicn (%) Gender Male14 (53.8) Female12 (46.1) Consanguinity Yes16 (61.5) No7 (26.9) Missing data3 (11.5) Family history of renal disease Yes12 (46.2) No13 (50.0) Missing data1 (3.8) Clinical presentation Generalised oedema10 (38.5) Abdominal distension7 (26.7) Lower limb oedema3 (11.5) Incidental finding3 (11.5) FH screening2 (7.7) Periorbital oedema1 (3.8) FH = familial hypercholesterolemia Characteristics of patients with congenital nephrotic syndrome at Royal Hospital, Muscat, Oman (N = 26). FH = familial hypercholesterolemia The mean age at presentation was 19.9 days (range: birth–2 months). Prematurity was noted in 57.7% and a large placenta was documented in 11.5% (n = 3). Extra-renal manifestations were noted, primarily endocrine in nature whereby 84.6% had hypothyroidism and 30.7% were noted to have short stature requiring growth hormone supplementation. This was followed by haematological manifestations, with 23.1% presented with anaemia and/or coagulation factor deficiencies. Hypercholesterolemia was noted in 50.0% of the patients [Table 2]. Table 2.Presentation of patients with congenital nephrotic syndrome at Royal Hospital, Muscat, Oman (N = 26).Presentationn (%) Amniotic fluid Polyhydramnios0 (0) Oligohydramnios3 (11.5) Missing data23 (88.5) Placenta size Large3 (11.5) Missing data23 (88.5) Gestational age Pre-term15 (57.7) Term10 (38.5) Missing data1 (3.8) Extra-renal manifestation * Eyes2 (7.7) Cardiac6 (23.1) Neurological3 (11.5) Respiratory5 (19.2) Syndromic4 (15.3) Protein/creatinine ratio High26 (100) Serum albumin Low26 (100) Serum cholesterol Low3 (11.5) High13 (50.0) Normal9 (34.6) Not done1 (3.8) Thyroid function status Hypothyroidism22 (84.6) Normal2 (7.7) Not done2 (7.7) Short stature 8 (30.7) Hematology 6 (23.1) (Anemia and/or coagulation abnormality)*6 patients did not have extra-renal manifestations, likely due to their early death within first 2 months of life. Presentation of patients with congenital nephrotic syndrome at Royal Hospital, Muscat, Oman (N = 26). 6 patients did not have extra-renal manifestations, likely due to their early death within first 2 months of life. In terms of infection workup, only 2 patients (7.7%) had positive cytomegalovirus (CMV) serology. A kidney biopsy was performed in only 3 patients and the findings were consistent with Finnish type. A total of 4 patients were diagnosed by clinical genetics as syndromic (2 patients with Pierson syndrome, 1 patient with Dandy-Walker syndrome and 1 patient with Bardet-Biedl syndrome). A genetic workup was performed on 19 patients, with positive genetic testing noted in 14 (73.6%). Of those, 12 patients (85.7%) were positive for NPHS1 gene, while NPHS2 and LAMB2 accounted for 7.1% each [Table 3]. Table 3.Evaluation of patients with congenital nephrotic syndrome at Royal Hospital, Muscat, Oman (N = 26).Evaluationn (%) Infection workup Positive CMV infection (both IgG and IgM)2 (7.7) Negative24 (92.3) Kidney biopsy Done3 (11.5) Not done23 (88.5) Histopathological finding of the Finnish type * 3 (11.5) Genetic workup Positive (n = 19)14 (73.6) NPHS1 (n = 14)12 (85.7) NPHS2 (n = 14)1 (7.1) Others (i.e., LAMB2; n = 14)1 (7.1) Negative5 (19.2) Not done7 (26.9) CMV = cytomegalovirus *Consisting of thin glomerular basement membrane with focal dense splitting, absence of podocyte foot processes differentiation, absence of foot process formation, wrinkle glomerular basement membrane and prominent lamina densa. Evaluation of patients with congenital nephrotic syndrome at Royal Hospital, Muscat, Oman (N = 26). CMV = cytomegalovirus Consisting of thin glomerular basement membrane with focal dense splitting, absence of podocyte foot processes differentiation, absence of foot process formation, wrinkle glomerular basement membrane and prominent lamina densa. The patients had a median follow-up time of 6.3 years (range: 1 month–13 years). A total of 23.1% initiated a form of dialysis and 15.4% were transplanted with no recurrence of the disease. One patient underwent unilateral nephrectomy for severe hypertension and proteinuria reduction. Two patients were lost to follow-up. Death was reported in 50.0% of the patients with a median age at death of 1.5 years (range: 1 month–7 years) [Table 4]. Table 4.Outcomes of patients with congenital nephrotic syndrome at Royal Hospital, Muscat, Oman (N = 26).Outcomen (%) Death 13 (50.0)Median age at death in years (range)1.5 (1 month–7 years) Nephrectomy + RRT 1 (3.5) RRT 6 (23.1)Median age at RRT in years (range)1.9 (birth–8 years) Kidney transplant 4 (15.4)Median age at kidney transplant in years (range)6 (6–10 years) Lost follow-up 3 (11.5)Median follow-up in years (range)6.3 (1 month–13years) RTT = renal replacement therapy Outcomes of patients with congenital nephrotic syndrome at Royal Hospital, Muscat, Oman (N = 26). RTT = renal replacement therapy 4. Discussion This retrospective cohort study of CNS in a paediatric population at the Royal Hospital in Oman provides valuable insights into the demographics, clinical presentations and genetic factors associated with the condition over a period of 20 years. Consanguinity rates are significantly higher in Middle Eastern countries, particularly in the Gulf region, compared to Western populations. In the current cohort, 61.5% of patients had consanguineous parents, which aligns with reports from Saudi Arabia, where consanguinity rates in similar cohorts range from 57.7% to 90%.45 A comparable study in Jordan reported up to 80% consanguinity rate.6 This high rate of consanguinity likely contributes to the increased prevalence of rare genetic disorders such as CNS but remains underreported in Gulf countries, with no documented incidence rates. In the current study, a positive family history of renal disease was observed in 46.2% of the patients, further emphasising the heritable nature of CNS. This finding is consistent with previous studies highlighting familial patterns in nephrotic syndrome.4567 CNS typically presents within the first three months of life. In the current cohort, most cases presented within the first month, with a mean age at presentation of 19.9 days, and 57.7% were premature which is consistent with international reports.1 Unfortunately, the majority of the current cohort lacked documentation on placental size, which has previously been reported to be disproportionately large relative to fetal size and is a finding that could provide further clues to justify clinical suspicion and prompt further evaluation.7 Oedema was the most common presenting symptom in the current cohort, observed in 80.5% of patients. This aligns with findings from many international studies.89 Of note, the oedema was variable in 42.0% of the cases and generalised oedema was limited to 38.5% of cases at presentation. Serum cholesterol levels were not highlighted in previous studies. In the current study, cholesterol was high in 13 patients (50.0%), in contrast to didactic traditional teaching evolving nephrotic syndrome. Screening for hypothyroidism revealed a high incidence of hypothyroid (84.6%) in this cohort, reflecting similar published findings confirming the common association of CNS with hypothyroidism which is due to the loss of thyroxine-binding globulin due to the significant proteinuria.10 CNS has been reported secondary to infectious causes, especially in developing countries. Most studies showed that CMV infection was the most common cause of CNS.8 On the contrary, the current stud only detected positive CMV serology (both IgM and IgG) in 2 patients only; CMV polymerase chain reaction was negative for both patients. Genetic workups have gained more popularity over the last decade becoming increasing important in diagnosis compared to more invasive procedure such as kidney biopsy.11 Genetic evaluation was performed in 19 patients in the current study; this was mostly done in the latter period of the study and performed in a sequential manner, starting with NPHS1 and proceeding with NPHS2 only if the initial result was negative, for cost effectivity. The most common gene mutation detected was NPHS1 (n = 12), 1 patient had NPHS2 and another patient had LAMB2 mutation. International studies similarly reported NPHS1 as the most common gene mutation followed by NPHS2.78 Local data from a neighbouring country reported similar pattern in causative genetic mutations detected in 69.4% of CNS patients of which 7 patients had NPHS1, 3 patients had LAMB2 and 1 patient had WT1 mutation.5 Kidney biopsy is not recommended according to the recent 2021 consensus by the ERKNet-ESPN Working Group.11 However, in the current study, 3 kidney biopsies were performed on CNS patients during the study period of 20 years. Histopathology revealed features of Finnish type which is consistent with the published literature.912 Pathology diagnosis was limited and reserved to cases that lack of positive genetic testing or sporadic cases. Management of CNS requires close multidisciplinary care aimed at supporting the child and family throughout the course of the disease. Treatment focuses on maintaining nutrition and growth, controlling oedema with albumin infusions and diuretics as well as monitoring for complications such as infections and thrombosis that may result from heavy urinary protein loss. Genetic testing is important for confirming the diagnosis and helping guide counselling and long-term planning. Some children, particularly those with severe Finnish-type disease, may eventually require dialysis and kidney transplantation, which remains the most effective long-term treatment option. The current study confirmed that management was initiated for almost all the patients as per international recommendations; outcomes were comparable to international reports.7 A total of 6 patients, who reached end stage renal disease, were initiated on renal dialysis (23.1%) at a median age of 1.9 years (range: 1 month–5 years). Four patients underwent kidney transplant with no disease recurrence. Nephrectomy was not readily performed at Royal Hospital, only one patient underwent unilateral nephrectomy for severe hypertension and proteinuria that remained poorly controlled despite medical therapy. CNS of the Finnish type is typically the most severe form, classically caused by mutations in the NPHS1 gene, presenting with heavy proteinuria and rapid progression to kidney failure, often requiring intensive support and kidney transplantation, with less extra-renal manifestation. Other forms of CNS show more variable severity and clinical features depending on the underlying genetic cause. The current study reported a mortality rate of 50.0%, with a median age at death of 1.5 years (range: 1 month–7 years), aligning with both international and regional findings.71213 Similar early presentations and high mortality rates (approximately 50%) have also been reported in a study from Saudi Arabia.5 These outcomes highlight the critical importance of early intervention, genetic diagnosis and multidisciplinary care. Despite the improvement in the management of CNS and early diagnosis, the prognosis is guarded with a mortality approximately 50%.810 Access and availability of supporting facilities is necessary to reduce mortality in addition to continuously updating guidelines. The predominance of genetic causes in the current cohort, together with the high mortality observed, highlights the importance of genetic counselling for affected families. This is particularly relevant in Oman, where consanguineous marriages remain common. Early counselling can help families understand the nature of the disease, the likelihood of recurrence in future pregnancies and the options available for family screening and prenatal diagnosis. Beyond supporting individual families, wider access to genetic services may contribute to reducing the burden of CNS in future generations. The main strength of the current study lies in the fact that no previous study has focused on CNS in the Omani population. Furthermore, it was conducted over a 20-year period at the main Paediatric Nephrology unit of the country. However, this study was subject to certain limitations. Referral bias may have been present as Royal Hospital is a referral tertiary centre for the entire country. The retrospective study design relied heavily on the original physician documentation for data quality and interpretation. Some variables had incomplete documentation, analyses were conducted based on available data and missing information may limit the interpretation of certain findings. Further accountable limitations include the small sample size and changing standards of care over 2 decades. 5. Conclusion This is the first reported data about CNS in Oman. Despite Oman being categorised as a developing country, CNS was rarely secondary to an infectious cause. Genetic mutations remain the main cause, especially with high consanguinity and positive family history of renal disease. The absence of anasarca and normal cholesterol may obscure the initial diagnosis, therefore, opting for early genetic testing may facilitate earlier diagnosis, genetic counselling and family planning. Further evaluation of the impact of genetic testing, early intervention and genetic counselling is recommended. Collaboration of data collection and analysis among neighbouring countries may benefit tailoring international guidelines to local needs and facilitate better resource planning. Authors’ Contribution Muzna Al Hashmi: Conceptualization, Methodology, Investigation, Data curation, Writing – Original Draft. Anisa Al Maskari: Investigation, Data curation, Writing – Review & Editing. Sulaiman Al Saidi: Formal analysis, Validation, Writing – Review & Editing. Badria Al Ghaithi: Formal analysis, Validation, Writing – Review & Editing. Mohammed Al Riyami: Methodology, Resources, Writing – Review & Editing. Naifain Al Kalbani: Conceptualization, Methodology, Supervision, Validation, Writing – Review & Editing, Project administration. Ethics Statement The study received ethical approval from Royal Hospital, Muscat, Oman (MoH/CSR/21/24480). Conflict of Interest The authors declare no conflicts of interest. Funding No funding was received for this study. Data Availability Data are available upon reasonable request from the corresponding author.